Mr. Randy Hung is currently the Director of Investor Relations of China Shineway Pharmaceutical Group Limited (stock code: 2877). He is a HKIRA fellow member and a holder of Certificate in Investor Relations issued by the UK Investor Relations Society.
Mr. Hung has served as an executive director, independent non-executive director, and senior management of listed companies for more than 20 years. He is a fellow certified public accountant of Hong Kong, and a licensed certified public accountant of the State of California in the USA.
Mr. Hung holds a MBA degree from the University of London, a bachelor of science degree in accounting and a certificate of programming and data processing from the University of Southern California, a certificate of China Accounting, Finance, Taxation and Law from the Chinese University of Hong Kong, a Hong Kong Securities Institute Specialist Certificate in corporate finance, and a holder of Executive Certificate in ESG Analysis & Green Finance Valuation issued by the Friends of the Earth.
He is also serving as a council member and the Chairman of Training Committee of the Hong Kong Institute of Directors.